| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |